September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
FDA approves 'dry' nasal aerosol to treat allergy symptoms
March 26th 2012FDA has approved beclomethasone dipropionate (QNASL Nasal Aerosol, Teva Pharmaceutical Industries), a ?dry? nasal aerosol corticosteroid that treats year-round and seasonal nasal allergy symptoms in people aged 12 years and older.
Study highlights need to treat nursing-home patients for vitamin D deficiency
March 22nd 2012The majority of older women in nursing homes are likely to be deficient in vitamin D during winter months, and those with the lowest levels are at a significantly increased risk of death, according to a study published online February 8, in the Journal of Clinical Endocrinology
New APhA president, Jenelle Sobotka, urges pharmacists 'to make a difference'
March 22nd 2012As pharmacy transforms into a patient-care model, everyone must "do what is needed to make a difference," Jenelle L. Sobotka, Ohio Northern University Raabe College of Pharmacy professor, said after she was sworn in as president of the American Pharmacists Association at its annual conference in New Orleans this month.
Ingenol mebutate gel is effective treatment for actinic keratosis, study shows
March 22nd 2012Ingenol mebutate topical gel (0.015% for face and scalp and 0.05% for trunk and extremities) was effective for treating actinic keratoses, a common precursor to sun-related, squamos-cell carcinoma, according to a new study.
Alzheimer's drugs donepezil, memantine show some benefits in study
March 22nd 2012A new study of patients with moderate to severe Alzheimer's disease found that extended treatment with donepezil could improve cognition and function for even severe patients; however, experts caution that the benefits of the drug were modest
Pharmacies benefitting from new programs, recognitions, Anne Burns says
March 20th 2012New programs and recognitions make 2012 a great year for community pharmacies to be more involved in medication therapy management, according to a speaker at the FMI Health & Wellness Conference in Orlando, Fla., this week.
Bootman honored as PPSI Distinguished Pharmacist of Year during APhA annual meeting
March 20th 2012J. Lyle Bootman, PhD, ScD, senior vice president for Health Sciences, dean and professor of Pharmacy, Medicine, and Public Health, University of Arizona, College of Pharmacy, was honored as the PPSI Distinguished Pharmacist of the Year, during PPSI’s annual breakfast, held during the American Pharmacists Association 2012 annual meeting in New Orleans.
FDA approves first oral contraceptive to treat heavy menstrual bleeding
March 15th 2012FDA has approved a new indication for estradiol valerate and estradiol valerate/dienogest (Natazia, Bayer HealthCare Pharmaceuticals) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus.
Study: Adding prednisone to treatment improves rheumatoid arthritis symptoms
March 15th 2012Patients' rheumatoid arthritis symptoms improved after adding prednisone at the start of a methotrexate-based treatment strategy, according to research published in the March 6 issue of the Annals of Internal Medicine.
APP Pharmaceuticals releasing more preservative-free methotrexate
March 15th 2012Continuing to work with FDA to ease the ongoing shortage of injectable methotrexate, APP Pharmaceuticals this week released another 10,000 vials of preservative-free methotrexate (Methotrexate Injection), a drug used in the treatment of pediatric oncology and hematology